COMP <GO>
QTTB vs JNJ // NET PROFIT MARGIN
Q32 Bio Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: QTTB 5
— JNJ 5
▲ NET PROFIT MARGIN LEADER: QTTB
LAST: $8.87 (-2.10%) • MKT CAP: $264.1M
net-margins
55.50%
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
net-margins
28.50%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (QTTB VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | QTTB | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 67.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 25.50% | +59.50 | QTTB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 12.8x | 18.5x | -5.70 | QTTB | /valuation <GO> |
| Free Cash Flow Yield | -12.70% | 2.97% | -15.67 | JNJ | /fcf-yield <GO> |
| Operating Margin | 31.50% | 34.70% | -3.20 | JNJ | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 55.50% | 28.50% | +27.00 | QTTB | /net-margins <GO> |
| Revenue Growth (YoY) | — | 6.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.99 | 5.59 | +0.40 | QTTB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 8/9 | -4.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.1 | 62.1 | -13.98 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 8.3x | 23.0x | -14.70 | QTTB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $264.1M | $662.49B | -$662.23B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | QTTB REV | JNJ REV | QTTB GROSS % | JNJ GROSS % | QTTB FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $53.7M | $94.19B | — | 67.9% | -$33.5M | $19.70B |
| FY 2024 | $0 | $88.82B | — | 69.1% | -$67.8M | $19.84B |
| FY 2023 | $1.2M | $85.16B | — | — | -$18.7M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
QTTB // BETA —
JNJ // BETA 1.08